James, thank you for presentation!
Could you please clarify - which brands of generics were used for REDEMPTION-1 trial, which result was presented at EASL-2016? Is this correct, that Bangladesh-made drugs was used (like Twinvir, Lesovir-C, Daclacee, Daclavir) and "chinese API" drugs? What is timeline of REDEMPTION-1 trial?
Is this correct that indian NS5A generics is used mainly in ongoing REDEMPTION-2 and REDEMPTION-3, not in REDEMPTION-1 trial?
Probably infected in 1977
2005 - diagnosed with HCV 1b, compensated F4, 15 mln viral load, ALT 320
2005-2006 - PegIFN/rib 48 weeks treatment, relapse
2016 - compensated F4, MELD 8-9, ALT 100-160
2018 - compensated F4, MELD 8, ALT 91